当前位置:首页 > 股票大全 > 南新制药 688189 财务分析

南新制药财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

南新制药(688189)利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入744,601,965.89562,058,852.86513,749,677.21303,227,799.34
营业总成本628,167,166.97508,120,982.75434,419,987.44248,034,131.32
营业利润7,412,231.1-4,929,907.4526,830,201.1918,595,451.64
利润总额7,607,254.86-1,900,148.5128,632,808.8919,295,009.75
净利润5,954,771.39998,459.6232,687,596.5914,364,549.6
其他综合收益----
综合收益总额5,954,771.39998,459.6232,687,596.5914,364,549.6
南新制药(688189)资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计1,290,011,027.371,231,656,921.131,416,428,938.781,631,204,722.21
非流动资产合计447,525,439.08445,571,216.65451,546,455.96438,712,690.99
资产总计1,737,536,466.451,677,228,137.781,867,975,394.742,069,917,413.2
流动负债合计429,441,961.38371,987,822.3530,644,295.41750,156,391.8
非流动负债合计5,768,065.327,870,187.58,271,834.399,024,803.44
负债合计435,210,026.7379,858,009.8538,916,129.8759,181,195.24
归属于母公司股东权益合计1,318,116,026.61,315,015,056.41,342,772,735.411,326,897,296.06
股东权益合计1,302,326,439.751,297,370,127.981,329,059,264.941,310,736,217.96
负债和股东权益合计1,737,536,466.451,677,228,137.781,867,975,394.742,069,917,413.2
南新制药(688189)现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计867,926,681.83626,379,760.43521,124,633.64254,908,380.51
经营活动现金流出小计652,696,154.54537,795,249.95468,682,320.11252,237,501.65
经营活动产生的现金流量净额215,230,527.2988,584,510.4852,442,313.532,670,878.86
投资活动现金流入小计61,100---
投资活动现金流出小计131,949,568.78,277,653.849,281,377.092,188,650.09
投资活动产生的现金流量净额-131,888,468.7-8,277,653.84-9,281,377.09-2,188,650.09
筹资活动现金流入小计438,800,000150,000,000115,000,00055,000,000
筹资活动现金流出小计673,884,639.76441,887,142.58249,837,173.5711,800,772.25
筹资活动产生的现金流量净额-235,084,639.76-291,887,142.58-134,837,173.5743,199,227.75
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-151,742,581.17-211,580,285.94-91,676,237.1343,681,456.52
期末现金及现金等价物余额561,729,383.46501,891,678.69621,795,727.5757,153,421.15
南新制药688189相关数据
今日股市大盘指数